MRONJ risk of adjuvant bisphosphonates in early stage breast cancer.

Patel, V

MRONJ risk of adjuvant bisphosphonates in early stage breast cancer. [electronic resource] - British dental journal Jan 2018 - 74-79 p. digital

Publication Type: Case Reports; Journal Article

1476-5373

10.1038/sj.bdj.2017.1039 doi


Adult
Bisphosphonate-Associated Osteonecrosis of the Jaw
Bone Density Conservation Agents--adverse effects
Breast Neoplasms--drug therapy
Diphosphonates
Female
Humans
Middle Aged
Neoplasm Recurrence, Local
Osteonecrosis